Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis) [Yahoo! Finance]
Flatiron Health announces research to be presented at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
Flatiron Health announces research to be presented at the 2025 San Antonio Breast Cancer Symposium
Roche shares hit milestone with 19% November surge on breast cancer and promising MS drug trials [Seeking Alpha]